Kristen SANDERS

Person

Gilmanton, NH, US

People

Patents Grantslast 30 patents

Information Patent Grant
Salt form of a human histone methyltransferase EZH2 inhibitor
- Patent number 12,251,386
- Issue date Mar 18, 2025
- Epizyme, Inc.
- Kevin Wayne Kuntz
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Crystalline FGFR4 inhibitor compound and uses thereof
- Patent number 11,498,916
- Issue date Nov 15, 2022
- Eisai R&D Management Co., Ltd.
- George Moniz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salt form of a human histone methyltransferase EZH2 inhibitor
- Patent number 11,491,163
- Issue date Nov 8, 2022
- Epizyme, Inc.
- Kevin Wayne Kuntz
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Salt form of a human histone methyltransferase EZH2 inhibitor
- Patent number 10,821,113
- Issue date Nov 3, 2020
- Epizyme, Inc.
- Kevin Wayne Kuntz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hydrochloride salt form for EZH2 inhibition
- Patent number 10,710,987
- Issue date Jul 14, 2020
- Epizyme, Inc.
- Kevin Wayne Kuntz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline FGFR4 inhibitor compound and uses thereof
- Patent number 10,562,888
- Issue date Feb 18, 2020
- Eisai R&D Management Co., Ltd.
- George Moniz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salt form of a human histone methyltransferase EZH2 inhibitor
- Patent number 10,245,269
- Issue date Apr 2, 2019
- Epizyme, Inc.
- Kevin Wayne Kuntz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydrochloride salt form for EZH2 inhibition
- Patent number 10,040,782
- Issue date Aug 7, 2018
- Epizyme, Inc.
- Kevin W. Kuntz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salt form of a human histone methyltransferase EZH2 inhibitor
- Patent number 9,872,862
- Issue date Jan 23, 2018
- Epizyme, Inc.
- Kevin Wayne Kuntz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salt form of a human histone methyltransferase EZH2 inhibitor
- Patent number 9,394,283
- Issue date Jul 19, 2016
- Epizyme, Inc.
- Kevin Wayne Kuntz
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR
- Publication number 20230140327
- Publication date May 4, 2023
- Epizyme, Inc.
- Kevin Wayne KUNTZ
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR
- Publication number 20210137936
- Publication date May 13, 2021
- Epizyme, Inc.
- Kevin Wayne KUNTZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HYDROCHLORIDE SALT FORM FOR EZH2 INHIBITION
- Publication number 20210017163
- Publication date Jan 21, 2021
- Epizyme, Inc.
- Kevin Wayne KUNTZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FGFR4 INHIBITOR COMPOUND AND USES THEREOF
- Publication number 20200317645
- Publication date Oct 8, 2020
- Eisai R&D Management Co., Ltd.
- George MONIZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR
- Publication number 20190269692
- Publication date Sep 5, 2019
- Epizyme, Inc.
- Kevin Wayne KUNTZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HYDROCHLORIDE SALT FORM FOR EZH2 INHIBITION
- Publication number 20180282312
- Publication date Oct 4, 2018
- Epizyme, Inc.
- Kevin Wayne KUNTZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR
- Publication number 20180243316
- Publication date Aug 30, 2018
- Epizyme, Inc.
- Kevin Wayne Kuntz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FGFR4 INHIBITOR COMPOUND AND USES THEREOF
- Publication number 20180093972
- Publication date Apr 5, 2018
- Eisai R&D Management Co., Ltd.
- George MONIZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR
- Publication number 20170143729
- Publication date May 25, 2017
- Epizyme, Inc.
- Kevin Wayne KUNTZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HYDROCHLORIDE SALT FORM FOR EZH2 INHIBITION
- Publication number 20160237068
- Publication date Aug 18, 2016
- Epizyme, Inc.
- Kevin W. KUNTZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR
- Publication number 20150065503
- Publication date Mar 5, 2015
- Epizyme, Inc.
- Kevin Wayne Kuntz
- C07 - ORGANIC CHEMISTRY

Kristen SANDERS

Person

Patents Grantslast 30 patents

Salt form of a human histone methyltransferase EZH2 inhibitor

Crystalline FGFR4 inhibitor compound and uses thereof

Salt form of a human histone methyltransferase EZH2 inhibitor

Salt form of a human histone methyltransferase EZH2 inhibitor

Hydrochloride salt form for EZH2 inhibition

Crystalline FGFR4 inhibitor compound and uses thereof

Salt form of a human histone methyltransferase EZH2 inhibitor

Hydrochloride salt form for EZH2 inhibition

Salt form of a human histone methyltransferase EZH2 inhibitor

Salt form of a human histone methyltransferase EZH2 inhibitor

Patents Applicationslast 30 patents

SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR

SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR

HYDROCHLORIDE SALT FORM FOR EZH2 INHIBITION

CRYSTALLINE FGFR4 INHIBITOR COMPOUND AND USES THEREOF

SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR

HYDROCHLORIDE SALT FORM FOR EZH2 INHIBITION

SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR

CRYSTALLINE FGFR4 INHIBITOR COMPOUND AND USES THEREOF

SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR

HYDROCHLORIDE SALT FORM FOR EZH2 INHIBITION

SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR